Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Asian J Psychiatr ; 96: 104047, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38640549

RESUMO

Psychopharmacotherapy for patients with schizophrenia in Japan has a long history of polypharmacy, which is rare worldwide but remains a critical problem. One reason for this is that clozapine was not available in Japan until 2009. We aimed to investigate the changes in psychopharmacotherapy in patients with schizophrenia over 12 years pre- and post-introduction of clozapine to clarify how psychopharmacotherapy for patients with schizophrenia has changed with the introduction of clozapine. We retrospectively collected data from the medical records of inpatients diagnosed with schizophrenia at the Okayama Psychiatric Medical Center. Chlorpromazine equivalent (CP-eq) decreased from 1276.6 mg/day in 2009 to 613.9 mg/day in 2020. The prescribed daily dose/defined daily dose (PDD/DDD) decreased from 3.0 in 2009 to 1.2 in 2020. The monotherapy rate increased from 24.4 % in 2009 to 74.6 % in 2020. Our institution began using clozapine in 2010, and the prescription rate for clozapine increased to 37.3 % in 2020. The prescription rate for more than three antipsychotics decreased from 27.8 % in 2009 to 0.8 % in 2020. The increase in clozapine prescription has contributed to an increased rate of antipsychotic monotherapy and a decreased rate of polypharmacy, promoting the optimization of schizophrenia medication. Clozapine therapy should be further promoted in Japan to reduce treatment-resistant schizophrenia due to polypharmacy as much as possible.


Assuntos
Antipsicóticos , Clozapina , Hospitais Psiquiátricos , Esquizofrenia , Humanos , Clozapina/uso terapêutico , Esquizofrenia/tratamento farmacológico , Japão , Antipsicóticos/uso terapêutico , Adulto , Feminino , Masculino , Estudos Retrospectivos , Pessoa de Meia-Idade , Hospitais Psiquiátricos/estatística & dados numéricos , Padrões de Prática Médica/estatística & dados numéricos , Polimedicação
2.
Sci Total Environ ; 857(Pt 3): 159719, 2023 Jan 20.
Artigo em Inglês | MEDLINE | ID: mdl-36302421

RESUMO

Improving the biomass retention and the sludge system stability to promote the full-scale application of anammox process is the focus of current related research. In this study, a calcium silicate hydrate functional material with calcium-releasing ability and weak alkalinity was used for an enhanced anammox process. In the long-term operation, an increase in the nitrogen removal rate (NRR) from 2.75 to 13.38 gN/L/d was achieved after 50 days of operation, with the abundance of Candidatus Kuenenia increased from 40.1 % to 47.0 %. The anammox activity was strengthened from 0.089 to 0.55 gN/gVSS/d over 50 days, with a growth rate being fitted at 0.0310 d-1. The resilience of the EGSB anammox system after inhibitions was investigated by substrate shock and low pH shock in long-term operation and batch test. Besides that, the phosphorus removal efficiency of the reactor reached up to 90 % under the positive effect of functional material. The functional material was shown to continuously provide calcium in the long-term for the reaction of hydroxyapatite (HAP) formation, which further improved the granular properties of the sludge and the biomass retention ability of the reactor. The promotion effect of functional material on the sludge granulation and anammox microbes retaining efficiency was the key for a high-resilience anammox EGSB reactor.


Assuntos
Reatores Biológicos , Esgotos , Esgotos/química , Anaerobiose , Biomassa , Cálcio , Oxidação Anaeróbia da Amônia , Oxirredução , Nitrogênio
3.
Chem Commun (Camb) ; 51(89): 16107-10, 2015 Nov 18.
Artigo em Inglês | MEDLINE | ID: mdl-26392151

RESUMO

Described herein is a highly enantioselective synthesis of fused piperidine and pyrrolidine derivatives with all-carbon stereogenic centers. The enantioselective reductive amination from C(s)-symmetric 1,3-dione derivatives proceeded in a highly stereoselective manner by taking advantage of the desymmetrization approach to afford fused heterocycles with contiguous stereogenic centers in good to excellent enantioselectivities (up to 98% ee).


Assuntos
Compostos Heterocíclicos/síntese química , Ácidos Fosfóricos/química , Catálise , Compostos Heterocíclicos/química , Piperidinas/química , Pirrolidinas/química , Estereoisomerismo
4.
Anal Chem ; 87(18): 9280-7, 2015 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-26320351

RESUMO

Proline cis-trans isomerization is known to play a key role in the rate-determining steps of protein folding. It is thus very important to understand the influence of environments, not only bulk solutions but also microenvironments such as interfaces, on the isomerization reaction of proline peptides. Here we present two HPLC methods for measurements of kinetic and equilibrium parameters for the isomerization reactions in bulk solutions and at liquid/solid interfaces. On-line temperature-jump relaxation HPLC (T-jump HPLC) allows the determination of forward and reverse rate constants of the isomerization in a bulk solution by monitoring the whole time course of conversion of pure isomers from both sides of the reaction, in contrast to other HPLC and capillary zone electrophoresis as well as spectrometric and calorimetric methods, which use a mixture of the isomers. We can then determine cis-trans isomerization barriers of the peptide at liquid/solid interfaces from the kinetic data obtained by dynamic on-column reaction HPLC and T-jump HPLC. We observed that the interconversion around the peptide bond for l-alanyl-l-proline (Ala-Pro) in water is accelerated at the surfaces of an alkyl-bonded silica and a poly(styrene-divinylbenzene) copolymer resin, and this is caused by a remarkable decrease in the enthalpy of activation. The molecular structures of the cis and trans forms of Ala-Pro estimated by quantum mechanics calculation reveal that an equilibrium shift toward the cis form as well as the rapid isomerization of Ala-Pro at the water/hydrophobic interfaces can be attributed to the lower polarity of the interfacial water at the surfaces of the hydrophobic materials compared to that of bulk water.


Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Dipeptídeos/química , Interações Hidrofóbicas e Hidrofílicas , Temperatura , Água/química , Cinética , Modelos Moleculares , Conformação Molecular , Poliestirenos/química , Dióxido de Silício/química , Soluções , Estereoisomerismo
5.
Pharmacol Biochem Behav ; 122: 240-5, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24732636

RESUMO

In the present study, we examined the effect of ACTH on the immobilization of rats in the forced swim test and hippocampal cell proliferation after administration of the 5-HT1A receptor agonist, R-(+)-8-hydroxy-2-di-n-propylamino tetralin ((+)-8-OH-DPAT). Chronic treatment with (+)-8-OH-DPAT (0.01-0.1 mg/kg, s.c.) significantly decreased the duration of immobility in saline- and ACTH-treated rats. Chronic administration of ACTH caused a significant decrease in hippocampal cell proliferation. However, (+)-8-OH-DPAT significantly normalized cell proliferation in ACTH-treated rats. We then investigated the effects of (+)-8-OH-DPAT on the expression of brain-derived neurotrophic factor (BDNF) and cyclin D1 (elements of cyclic adenosine monophosphate response element-binding protein (CREB)-BDNF and Wnt signaling pathways, respectively) in the hippocampus of saline- and ACTH-treated rats. ACTH treatment significantly decreased the expression of cyclin D1, while treatment with (+)-8-OH-DPAT normalized the expression of cyclin D1 in ACTH-treated rats. However, the expression of BDNF did not change in either saline- or ACTH-treated rats. These findings suggest that the antidepressant effects of (+)-8-OH-DPAT in treatment-resistant animals may be attributed to an enhancement of hippocampal cell proliferation, at least in part due to an enhancement of cyclin D1 expression.


Assuntos
8-Hidroxi-2-(di-n-propilamino)tetralina/farmacologia , Hormônio Adrenocorticotrópico/toxicidade , Proliferação de Células/efeitos dos fármacos , Hipocampo/efeitos dos fármacos , Imobilização/psicologia , Natação/psicologia , 8-Hidroxi-2-(di-n-propilamino)tetralina/uso terapêutico , Animais , Antidepressivos/farmacologia , Antidepressivos/uso terapêutico , Proliferação de Células/fisiologia , Depressão/tratamento farmacológico , Depressão/patologia , Depressão/psicologia , Hipocampo/citologia , Hipocampo/fisiologia , Imobilização/fisiologia , Masculino , Ratos , Ratos Wistar , Fatores de Tempo
6.
Yakugaku Zasshi ; 132(2): 173-8, 2012.
Artigo em Japonês | MEDLINE | ID: mdl-22293695

RESUMO

We previously reported that adrenocorticotropic hormone (ACTH)-treated rats serve as a valuable animal model for tricyclic antidepressant-resistant depressive conditions. The present study was undertaken to investigate the changes in neurogenesis in the hippocampus of ACTH-treated rats. Chronic treatment of ACTH decreased the number of bromodeoxyuridine-labeled cells in the dentate gyrus, and the coadministration of imipramine and lithium, and electroconvulsive stimuli recovered these reductions. Furthermore, chronic ACTH treatment also decreased the expression of brain-derived neurotrophic factor, and the coadministration of imipramine and lithium, and electroconvulsive stimuli recovered these reductions. These results suggest that antidepressant-resistant depression is caused by the suppression of neurogenesis, and the coadministration of imipramine and lithium, and electroconvulsive stimuli exert an antidepressant-like effect by recovering proliferative signals and neurogenesis.


Assuntos
Hormônio Adrenocorticotrópico/efeitos adversos , Proliferação de Células/efeitos dos fármacos , Giro Denteado/citologia , Transtorno Depressivo Resistente a Tratamento/patologia , Hipocampo , Neurogênese/efeitos dos fármacos , Hormônio Adrenocorticotrópico/administração & dosagem , Animais , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Depressão Química , Transtorno Depressivo Resistente a Tratamento/terapia , Modelos Animais de Doenças , Eletroconvulsoterapia , Imipramina/uso terapêutico , Lítio/uso terapêutico , Ratos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...